Authors:
Joanne Xiu, Wafik S. El-Deiry, Paul M. Campbell, Lanlan Zhou, James S. Duncan, Zoran Gatalica, Sandeep K. Reddy, Jonathan Chernoff, Steven J. Cohen
Background
KRAS, NRAS and HRAS are functionally and structurally close proto-oncogenes with conserved sequences at important functional regions. Mutated Ras family members promote oncogenesis, cause cell proliferation and survival and confer resistance to anti-EGFR therapy. We hypothesized Ras family mutations have variable molecular and clinical features including in metastasis of CRC.
Download PublicationCookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |